Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Trichomonas vaginalis | beta-hexosaminidase B, putative | 0.0581 | 0 | 0.5 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0581 | 0 | 0.5 |
Trichomonas vaginalis | alpha-L-fucosidase, putative | 0.0581 | 0 | 0.5 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0581 | 0 | 0.5 |
Brugia malayi | Protein kinase domain containing protein | 0.4698 | 0.3691 | 0.5 |
Mycobacterium leprae | PROBABLE CONSERVED TRANSMEMBRANE PROTEIN | 0.0581 | 0 | 0.5 |
Schistosoma mansoni | btb and poz domain-containing protein | 0.0581 | 0 | 0.5 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0581 | 0 | 0.5 |
Trichomonas vaginalis | hypothetical protein | 0.0581 | 0 | 0.5 |
Schistosoma mansoni | hypothetical protein | 0.0581 | 0 | 0.5 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0581 | 0 | 0.5 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0581 | 0 | 0.5 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0581 | 0 | 0.5 |
Echinococcus multilocularis | discoidin domain receptor | 0.0581 | 0 | 0.5 |
Echinococcus granulosus | discoidin domain receptor | 0.4639 | 0.3638 | 0.3638 |
Loa Loa (eye worm) | hypothetical protein | 0.4639 | 0.3638 | 1 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0581 | 0 | 0.5 |
Toxoplasma gondii | F5/8 type C domain-containing protein | 0.0581 | 0 | 0.5 |
Echinococcus multilocularis | discoidin domain containing receptor 2 | 0.0581 | 0 | 0.5 |
Plasmodium falciparum | LCCL domain-containing protein | 0.0581 | 0 | 0.5 |
Echinococcus multilocularis | discoidin domain containing receptor 2 | 0.0581 | 0 | 0.5 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0581 | 0 | 0.5 |
Plasmodium falciparum | LCCL domain-containing protein | 0.0581 | 0 | 0.5 |
Onchocerca volvulus | 0.4698 | 0.3691 | 1 | |
Toxoplasma gondii | PA14 domain-containing protein | 0.0581 | 0 | 0.5 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0581 | 0 | 0.5 |
Schistosoma mansoni | dock | 0.0581 | 0 | 0.5 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0581 | 0 | 0.5 |
Echinococcus multilocularis | discoidin domain containing receptor 2 | 0.0581 | 0 | 0.5 |
Toxoplasma gondii | F5/8 type C domain-containing protein | 0.0581 | 0 | 0.5 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0581 | 0 | 0.5 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0581 | 0 | 0.5 |
Trichomonas vaginalis | alpha-L-fucosidase, putative | 0.0581 | 0 | 0.5 |
Mycobacterium tuberculosis | Possible arabinofuranosyltransferase AftD | 0.0581 | 0 | 0.5 |
Toxoplasma gondii | F5/8 type C domain-containing protein | 0.0581 | 0 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.4117 | 0.317 | 0.8714 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0581 | 0 | 0.5 |
Loa Loa (eye worm) | TK/DDR protein kinase | 0.4117 | 0.317 | 0.8714 |
Schistosoma mansoni | discoidin domain receptor | 0.0581 | 0 | 0.5 |
Plasmodium vivax | LCCL domain-containing protein | 0.0581 | 0 | 0.5 |
Plasmodium vivax | LCCL domain-containing protein | 0.0581 | 0 | 0.5 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0581 | 0 | 0.5 |
Echinococcus multilocularis | Coagulation factor 5 8 type, C terminal | 0.0581 | 0 | 0.5 |
Echinococcus multilocularis | nuclear receptor 2C2 associated protein | 0.0581 | 0 | 0.5 |
Schistosoma mansoni | discoidin domain receptor | 0.0581 | 0 | 0.5 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0581 | 0 | 0.5 |
Schistosoma mansoni | septate junction protein | 0.0581 | 0 | 0.5 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
EC50 (functional) | > 150 uM | PUBCHEM_BIOASSAY: Fluorescence Cell-Based Secondary Assay to Identify Inhibitors of Resistant C. albicans Growth in the Presence of Fluconazole. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID1979, AID2007] | ChEMBL. | No reference |
Potency (functional) | = 25.1189 um | PUBCHEM_BIOASSAY: qHTS Assay for Agonists of the Thyroid Stimulating Hormone Receptor. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | = 25.1189 um | PUBCHEM_BIOASSAY: qHTS Assay for Agonists of the Thyroid Stimulating Hormone Receptor: Activators of Intracellular cAMP Concentrations in Parental HEK 293. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | = 39.8107 um | PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Aldehyde Dehydrogenase 1 (ALDH1A1). (Class of assay: confirmatory) [Related pubchem assays: 1030 (qHTS Validation Assay for Inhibitors of aldehyde dehydrogenase 1 (ALDH1A1))] | ChEMBL. | No reference |
Potency (functional) | = 44.6684 um | PUBCHEM_BIOASSAY: qHTS Assay for the Inhibitors of Schistosoma Mansoni Peroxiredoxins. (Class of assay: confirmatory) [Related pubchem assays: 1011 (Confirmation Concentration-Response Assay for Inhibitors of the Schistosoma mansoni Redox Cascade ), 448 (Schistosoma Mansoni Peroxiredoxins (Prx2) and thioredoxin glutathione reductase (TGR) coupled assay)] | ChEMBL. | No reference |
Potency (functional) | = 56.2341 um | PUBCHEM_BIOASSAY: qHTS Inhibitors of AmpC Beta-Lactamase (assay with detergent). (Class of assay: confirmatory) [Related pubchem assays: 1002 (Confirmation Concentration-Response Assay for Inhibitors of AmpC Beta-Lactamase (assay with detergent)), 585 (Promiscuous and Specific Inhibitors of AmpC Beta-Lactamase (assay without detergent) - a screen old NIH MLSMR collection), 584 (Promiscuous and Specific Inhibitors of AmpC Beta-Lactamase (assay with detergent) - a screen of the old NIH MLSMR collection), 1003 (Confirmation Cuvette-Based Assay for Inhibitors of AmpC Beta-Lactamase (assay with detergent))] | ChEMBL. | No reference |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.